Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2011, Article ID 712150, 9 pages
http://dx.doi.org/10.1155/2011/712150
Review Article

Choice and Duration of Antimicrobial Therapy for Neonatal Sepsis and Meningitis

1Division of Neonatology, Department of Pediatrics, University of Calgary, Calgary, AB, Canada T2N 1N4
2Institute for Maternal and Child Health, University of Calgary, Calgary, AB, Canada T2N 4N1

Received 30 June 2011; Accepted 4 October 2011

Academic Editor: N. B. Mathur

Copyright © 2011 Sindhu Sivanandan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. O. Klein, “Bacteriology of neonatal sepsis,” Pediatric Infectious Disease Journal, vol. 9, no. 10, pp. 777s–778, 1990. View at Google Scholar · View at Scopus
  2. B. J. Stoll, N. I. Hansen, P. J. Sánchez et al., “Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues,” Pediatrics, vol. 127, no. 5, pp. 817–826, 2011. View at Publisher · View at Google Scholar
  3. B. Muller-Pebody, A. P. Johnson, P. T. Heath, R. E. Gilbert, K. L. Henderson, and M. Sharland, “Empirical treatment of neonatal sepsis: are the current guidelines adequate?” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 96, no. 1, pp. F4–F8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. B. J. Stoll, N. Hansen, A. A. Fanaroff et al., “Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network,” Pediatrics, vol. 110, no. 2, pp. 285–291, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Isaacs, “A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 88, no. 2, pp. F89–F93, 2003. View at Google Scholar · View at Scopus
  6. A. K. M. Zaidi, D. Thaver, S. A. Ali, and T. A. Khan, “Pathogens associated with sepsis in newborns and young infants in developing countries,” Pediatric Infectious Disease Journal, vol. 28, no. 1, pp. S10–S18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Mulholland, P. Margolis, K. Mason et al., “Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study,” Pediatric Infectious Disease Journal, vol. 18, no. 10, pp. S17–S22, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. “Report of the National Neonatal Perinatal Database (National Neonatology Forum),” 2002-2003.
  9. V. Sundaram, P. Kumar, S. Dutta et al., “Blood culture confirmed bacterial sepsis in neonates in a north Indian tertiary care center: changes over the last decade,” Japanese Journal of Infectious Diseases, vol. 62, no. 1, pp. 46–50, 2009. View at Google Scholar · View at Scopus
  10. R. S. Baltimore, S. M. Huie, J. I. Meek, A. Schuchat, and K. L. O'Brien, “Early-onset neonatal sepsis in the era of group B streptococcal prevention,” Pediatrics, vol. 108, no. 5, pp. 1094–1098, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. B. J. Stoll, N. Hansen, A. A. Fanaroff et al., “Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants,” The New England Journal of Medicine, vol. 347, no. 4, pp. 240–247, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. R. Hammerschlag, J. O. Klein, M. Herschel, F. C. Chen, and R. Fermin, “Patterns of use of antibiotics in two newborn nurseries,” The New England Journal of Medicine, vol. 296, no. 22, pp. 1268–1269, 1977. View at Google Scholar · View at Scopus
  13. E. I. Mtitimila and R. W. Cooke, “Antibiotic regimens for suspected early neonatal sepsis,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD004495, 2004. View at Google Scholar · View at Scopus
  14. A. H. Dawodu and C. E. Effiong, “Neonatal mortality: effects of selective pediatric interventions,” Pediatrics, vol. 75, no. 1, pp. 51–57, 1985. View at Google Scholar · View at Scopus
  15. P. Margolis, E. K. Mulholland, F. Harrell et al., “Clinical prediction of serious bacterial infections in young infants in developing countries,” Pediatric Infectious Disease Journal, vol. 18, no. 10, pp. S23–S31, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. J. R. Verani, L. McGee, and S. J. Schrag, “Prevention of perinatal group B streptococcal disease revised guidelines from CDC,” Morbidity and Mortality Weekly Report, vol. 19, no. 10, pp. 1–36, 2010. View at Google Scholar · View at Scopus
  17. “Methodology for a multicenter study of serious infections in young infants in developing countries,” Pediatric Infectious Disease Journal, vol. 18, no. 10, supplement, pp. S8–S16, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. J. S. Gerdes, “Diagnosis and management of bacterial infections in the neonate,” Pediatric Clinics of North America, vol. 51, no. 4, pp. 939–959, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Snelling, C. A. Hart, and R. W. I. Cooke, “Ceftazidime or gentamicin plus benzylpenicillin in neonates less than forty-eight hours old,” Journal of Antimicrobial Chemotherapy, vol. 12, pp. 353–356, 1983. View at Google Scholar · View at Scopus
  20. V. M. Miall-Allen, A. G. L. Whitelaw, and J. H. Darrell, “Ticarcillin plus clavulanic acid (Timentin) compared with standard antibiotic regimes in the treatment of early and late neonatal infections,” British Journal of Clinical Practice, vol. 42, no. 7, pp. 273–279, 1988. View at Google Scholar · View at Scopus
  21. T. Metsvaht, M. L. Ilmoja, Ü. Parm, L. Maipuu, M. Merila, and I. Lutsar, “Comparison of ampicillin plus gentamicin vs. penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis,” Acta Paediatrica, International Journal of Paediatrics, vol. 99, no. 5, pp. 665–672, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. O. Klein, “Bacterial sepsis and meningitis,” in Infectious Disaeses of the Fetus and Newborn Infant, J. S. Remington and J. O. Klein, Eds., pp. 247–295, WB Saunders, Philadelphia, Pa, USA, 6th edition, 2006. View at Google Scholar
  23. American Academy of Pediatrics, “Group B streptococcal infections,” in Red Book: 2009 Report of the Committee on Infectious Diseases, L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long, Eds., pp. 628–634, American Academy of Pediatrics, Elk Grove Village, Ill, USA, 28th edition, 2009. View at Google Scholar
  24. R. S. Baltimore, “Neonatal Sepsis: epidemiology and Management,” Pediatric Drugs, vol. 5, no. 11, pp. 723–740, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Lubell, E. A. Ashley, C. Turner, P. Turner, and N. J. White, “Susceptibility of community-acquired pathogens to antibiotics in Africa and Asia in neonates—an alarmingly short review,” Tropical Medicine and International Health, vol. 16, no. 2, pp. 145–151, 2011. View at Publisher · View at Google Scholar
  26. J. E. Lawn, S. Cousens, and J. Zupan, “4 Million neonatal deaths: when? Where? Why?” Lancet, vol. 365, no. 9462, pp. 891–900, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. G. Karlowicz, E. S. Buescher, and A. E. Surka, “Fulminant late-onset sepsis in a neonatal intensive care unit, 1988–1997, and the impact of avoiding empiric vancomycin therapy,” Pediatrics, vol. 106, no. 6, pp. 1387–1390, 2000. View at Google Scholar · View at Scopus
  28. A. K. M. Zaidi, W. C. Huskins, D. Thaver, Z. A. Bhutta, Z. Abbas, and D. A. Goldmann, “Hospital-acquired neonatal infections in developing countries,” Lancet, vol. 365, no. 9465, pp. 1175–1188, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Gordon and H. E. Jeffery, “Antibiotic regimens for suspected late onset sepsis in newborn infants,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD004501, 2005. View at Google Scholar · View at Scopus
  30. D. K. Benjamin, E. R. DeLong, W. J. Steinbach, C. M. Cotton, T. J. Walsh, and R. H. Clark, “Empirical therapy for neonatal candidemia in very low birth weight infants,” Pediatrics, vol. 112, no. 3, pp. 543–547, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Kaufman and K. D. Fairchild, “Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants,” Clinical Microbiology Reviews, vol. 17, no. 3, pp. 638–680, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. B. J. Stoll, T. Gordon, S. B. Korones et al., “Early-onset sepsis in very low birth weight neonates: a report from the national institute of child health and human development neonatal research network,” Journal of Pediatrics, vol. 129, no. 1, pp. 72–80, 1996. View at Google Scholar · View at Scopus
  33. H. Kaftan and J. S. Kinney, “Early onset neonatal bacterial infections,” Seminars in Perinatology, vol. 22, no. 1, pp. 15–24, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Cordero, “Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program,” Infection Control and Hospital Epidemiology, vol. 20, no. 4, pp. 242–246, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. M. E. Pichichero and J. K. Todd, “Detection of neonatal bacteremia,” Journal of Pediatrics, vol. 94, no. 6, pp. 958–960, 1979. View at Google Scholar · View at Scopus
  36. J. A. Garcia-Prats, T. R. Cooper, V. F. Schneider, C. E. Stager, and T. N. Hansen, “Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system,” Pediatrics, vol. 105, no. 3, pp. 523–527, 2000. View at Google Scholar · View at Scopus
  37. S. S. Saini, S. Dutta, P. Ray, and A. Narang, “Short course versus 7-day course of intravenous antibiotics for probable neonatal septicemia: a pilot, open-label, randomized controlled trial,” Indian Pediatrics, vol. 48, no. 1, pp. 19–24, 2011. View at Publisher · View at Google Scholar
  38. L. Cordero and L. W. Ayers, “Duration of empiric antibiotics for suspected early-onset sepsis in extremely low birth weight infants,” Infection Control and Hospital Epidemiology, vol. 24, no. 9, pp. 662–666, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. W. E. Benitz, M. Y. Han, A. Madan, and P. Ramachandra, “Serial serum C-reactive protein levels in the diagnosis of neonatal infection,” Pediatrics, vol. 102, no. 4, p. E41, 1998. View at Google Scholar · View at Scopus
  40. H. N. Bomela, D. E. Ballot, B. J. Cory, and P. A. Cooper, “Use of C-reactive protein to guide duration of empiric antibiotic therapy in suspected early neonatal sepsis,” Pediatric Infectious Disease Journal, vol. 19, no. 6, pp. 531–535, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. A. G. Philip and P. C. Mills, “Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery,” Pediatrics, vol. 106, no. 1, p. E4, 2000. View at Google Scholar · View at Scopus
  42. S. Ehl, B. Gering, P. Bartmann, J. Högel, and F. Pohlandt, “C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection,” Pediatrics, vol. 99, no. 2, pp. 216–221, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. R. S. Jaswal, R. K. Kaushal, A. Goel, and K. Pathania, “Role of C-reactive protein in deciding duration of antibiotic therapy in neonatal septicemia,” Indian Pediatrics, vol. 40, no. 9, pp. 880–883, 2003. View at Google Scholar · View at Scopus
  44. E. J. Al-Zwaini, “C-reactive protein: a useful marker for guiding duration of antibiotic therapy in suspected neonatal septicaemia?” Eastern Mediterranean Health Journal, vol. 15, no. 2, pp. 269–275, 2009. View at Google Scholar · View at Scopus
  45. E. N. Squire Jr., H. M. Reich, G. B. Merenstein, B. E. Favara, and J. K. Todd, “Criteria for the discontinuation of antibiotic therapy during presumptive treatment of suspected neonatal infection,” Pediatric Infectious Disease, vol. 1, no. 2, pp. 85–90, 1982. View at Google Scholar · View at Scopus
  46. R. Bennet, M. Eriksson, C. E. Nord, and R. Zetterstrom, “Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens,” Pediatric Infectious Disease, vol. 5, no. 5, pp. 533–539, 1986. View at Google Scholar · View at Scopus
  47. D. M. Shlaes, D. N. Gerding, J. F. John Jr. et al., “Society for healthcare epidemiology of america and infectious diseases society of america joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals,” Clinical Infectious Diseases, vol. 25, no. 3, pp. 584–599, 1997. View at Google Scholar · View at Scopus
  48. C. Michael Cotten, S. Taylor, B. Stoll et al., “Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants,” Pediatrics, vol. 123, no. 1, pp. 58–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. R. H. Clark, B. T. Bloom, A. R. Spitzer, and D. R. Gerstmann, “Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death,” Pediatrics, vol. 117, no. 1, pp. 67–74, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. C. M. Cotten, S. McDonald, B. Stoll, R. N. Goldberg, K. Poole, and D. K. Benjamin, “The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants,” Pediatrics, vol. 118, no. 2, pp. 717–722, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. D. K. Benjamin, B. J. Stoll, A. A. Fanaroff et al., “Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months,” Pediatrics, vol. 117, no. 1, pp. 84–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. I. H. Gewolb, R. S. Schwalbe, V. L. Taciak, T. S. Harrison, and P. Panigrahi, “Stool microflora in extremely low birthweight infants,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 80, no. 3, pp. F167–F173, 1999. View at Google Scholar · View at Scopus
  53. W. D. Engle, G. L. Jackson, D. Sendelbach et al., “Neonatal pneumonia: comparison of 4 vs 7 days of antibiotic therapy in term and near-term infants,” Journal of Perinatology, vol. 20, no. 7, pp. 421–426, 2000. View at Google Scholar · View at Scopus
  54. G. Chowdhary, S. Dutta, and A. Narang, “Randomized controlled trial of 7-day vs. 14-day antibiotics for neonatal sepsis,” Journal of Tropical Pediatrics, vol. 52, no. 6, pp. 427–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Gathwala, A. Sindwani, J. Singh, O. Choudhry, and U. Chaudhary, “Ten days vs. 14 days antibiotic therapy in culture-proven neonatal sepsis,” Journal of Tropical Pediatrics, vol. 56, no. 6, pp. 433–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. A. R. Tunkel, B. J. Hartman, S. L. Kaplan et al., “Practice guidelines for the management of bacterial meningitis,” Clinical Infectious Diseases, vol. 39, no. 9, pp. 1267–1284, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Sáez-Llorens and G. H. McCracken, “Bacterial meningitis in children,” Lancet, vol. 361, no. 9375, pp. 2139–2148, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. M. W. Kline, “Citrobacter meningitis and brain abscess in infancy: epidemiology, pathogenesis, and treatment,” Journal of Pediatrics, vol. 113, no. 3, pp. 430–434, 1988. View at Google Scholar · View at Scopus
  59. M. Unhanand, M. M. Mustafa, G. H. McCracken, and J. D. Nelson Jr., “Gram-negative enteric bacillary meningitis: a twenty-one-year experience,” Journal of Pediatrics, vol. 122, no. 1, pp. 15–21, 1993. View at Publisher · View at Google Scholar · View at Scopus
  60. D. E. Karageorgopoulos, P. E. Valkimadi, A. Kapaskelis, P. I. Rafailidis, and M. E. Falagas, “Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children,” Archives of Disease in Childhood, vol. 94, no. 8, pp. 607–614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. P. N. Goldwater, “Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children,” International Journal of Antimicrobial Agents, vol. 26, no. 5, pp. 408–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. A. S. Daoud, A. Batieha, M. Al-Sheyyab, F. Abuekteish, A. Obeidat, and T. Mahafza, “Lack of effectiveness of dexamethasone in neonatal bacterial meningitis,” European Journal of Pediatrics, vol. 158, no. 3, pp. 230–233, 1999. View at Publisher · View at Google Scholar · View at Scopus